Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Other Working Capital Changes (2016 - 2025)

International Stem Cell (ISCO) has disclosed Other Working Capital Changes for 16 consecutive years, with -$407000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Other Working Capital Changes fell 120.0% to -$407000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$257000.0, a 229.8% decrease, with the full-year FY2024 number at $27000.0, up 350.0% from a year prior.
  • Other Working Capital Changes was -$407000.0 for Q3 2025 at International Stem Cell, down from $230000.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $311000.0 in Q2 2023 to a low of -$496000.0 in Q3 2021.
  • A 5-year average of -$23473.7 and a median of -$21000.0 in 2021 define the central range for Other Working Capital Changes.
  • Peak YoY movement for Other Working Capital Changes: soared 1333.33% in 2021, then tumbled 209.77% in 2022.
  • International Stem Cell's Other Working Capital Changes stood at $215000.0 in 2021, then crashed by 209.77% to -$236000.0 in 2022, then skyrocketed by 174.15% to $175000.0 in 2023, then tumbled by 97.71% to $4000.0 in 2024, then tumbled by 10275.0% to -$407000.0 in 2025.
  • Per Business Quant, the three most recent readings for ISCO's Other Working Capital Changes are -$407000.0 (Q3 2025), $230000.0 (Q2 2025), and -$84000.0 (Q1 2025).